The US shift toward steep tariffs will likely make drugs more expensive and limit access for patients, according to one of ...

This leaflet answers some common questions about Carbamazepine Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the ...

ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis, the bookrunner on the deal ...

it is imperative they have access to important medication that will help best manage their health." said Mark Levick, global head of development, biopharmaceuticals, Sandoz. "The FDA's acceptance ...

Quetiapine is an antipsychotic medication that people who live with ... The companies whose products are in shortage — Arrotex, Sandoz and Accord Healthcare — have blamed manufacturing ...

More than a third (33%) of essential generic medicines were withdrawn from the Portuguese market in the last ten years, according to an analysis by Israeli pharmaceutical company Teva. The sector's ...

Most generics and biosimilars in the US contain ingredients made elsewhere or are produced entirely abroad, which will hit consumers immediately, Richard Saynor, the chief executive officer of Sandoz ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in ...